NCT06814145

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-04-16Est. Completion: 2035-08-10

Enrollment target: 130 participants

Locations

Pulmonary Associates, PA ( Site 1008), Phoenix, Arizona, United States
Scripps Clinic John R Anderson V Medical Pavillion ( Site 1004), La Jolla, California, United States
Jeffrey S. Sager, MD Medical Corporation ( Site 1060), Santa Barbara, California, United States
Stanford University Medical Center ( Site 1024), Stanford, California, United States
South Denver Cardiology Associates ( Site 1091), Littleton, Colorado, United States
Yale New Haven Hospital ( Site 1093), New Haven, Connecticut, United States
AdventHealth Orlando ( Site 1058), Orlando, Florida, United States
The Emory Clinic ( Site 1030), Atlanta, Georgia, United States
Norton Pulmonary Specialists ( Site 1066), Louisville, Kentucky, United States
University Of Nebraska Medical Center ( Site 1053), Omaha, Nebraska, United States
Weill Cornell Medical Center ( Site 1046), New York, New York, United States
Duke University Medical Center ( Site 1026), Durham, North Carolina, United States
The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital ( Site 1001), Cincinnati, Ohio, United States

Chronic Venous Insufficiency, CVI

This is a prospective, single-arm, pre-post interventional study designed to evaluate the feasibility, safety, and impac…

Bydgoszcz, PolandCompleted May 10, 2028

Scleroderma, Systemic

The goal of this clinical trial is to evaluate whether anti-CD19 CAR T-cell therapy can improve disease activity in adul…

Lille, FranceEst. completion Aug 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.